|
1
|
Gradishar WJ, Moran MS, Abraham J, Aft R,
Agnese D, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD, et
al: NCCN guidelines® insights: Breast cancer, version
4.2021. J Natxl Compr Canc Netw. 19:484–493. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Lv X, Xu X, Gao X and Wang B:
Meta-analysis for psychological impact of breast reconstruction in
patients with breast cancer. Breast Cancer. 25:464–469. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maass SW, Roorda C, Berendsen AJ, Verhaak
PF and de Bock GH: The prevalence of long-term symptoms of
depression and anxiety after breast cancer treatment: A systematic
review. Maturitas. 82:100–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Padmalatha S, Tsai YT, Ku HC, Wu YL, Yu T,
Fang SY and Ko NY: Higher risk of depression after total mastectomy
versus breast reconstruction among adult women with breast cancer:
A systematic review and metaregression. Clin Breast Cancer.
21:e526–e538. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chopra D and Robb G: Body image: Integral
aspect of psychosocial evaluation for patients undergoing breast
reconstruction. Breast J. 26:1929–1930. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Wang X, Thomsen JB, Nahabedian MY,
Ishii N, Rozen WM, Long X and Ho YS: Research trends and
performances of breast reconstruction: A bibliometric analysis. Ann
Transl Med. 8:15292020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rodby KA, Robinson E, Danielson KK, Quinn
KP and Antony AK: Age-dependent characteristics in women with
breast cancer: Mastectomy and reconstructive trends at an urban
academic institution. Am Surg. 82:227–235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
See MH, Sinnadurai S, Lai LL, Tan KL, The
MS, Teoh LY, Jamaris S, Abdul Malik R and Bhoo-Pathy N: Outcomes
after mastectomy with immediate breast reconstruction for breast
cancer in a multiethnic, middle-income Asian setting. Surgery.
170:1604–1609. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Agarwal J, Agarwal S, Pappas L and
Neumayer L: A population-based study of breast cancer-specific
survival following mastectomy and immediate or early-delayed breast
reconstruction. Breast J. 18:226–232. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ou KW, Yu JC, Ho MH, Chiu WK, Ou KL, Chen
TM and Chen SG: Oncological safety and outcomes of nipple-sparing
mastectomy with breast reconstruction: A single-centered experience
in Taiwan. Ann Plast Surg. 74 (Suppl 2):S127–S131. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ali AM, Provenzano E, Bartlett JM, Abraham
J, Driver K, Munro AF, Twelves C, Poole CJ, Hiller L, Dunn JA, et
al: Prognosis of early breast cancer by immunohistochemistry
defined intrinsic sub-types in patients treated with adjuvant
chemotherapy in the NEAT/BR9601 trial. Int J Cancer. 133:1470–1478.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu F, Hu CH, Jiang SA, Lu FG, Lin MH and
Deng XG: Herceptin plus adjuvant chemotherapy for the prognosis of
patients with human epithelial growth factor receptor 2 positive
early-stage breast cancer: A meta-analysis. Zhong Nan Da Xue Xue
Bao Yi Xue Ban. 32:684–689. 2007.(In Chinese). PubMed/NCBI
|
|
13
|
Bonneterre J, Roché H, Kerbrat P, Brémond
A, Fumoleau P, Namer M, Goudier MJ, Schraub S, Fargeot P and
Chapelle-Marcillac I: Epirubicin increases long-term survival in
adjuvant chemotherapy of patients with poor-prognosis,
node-positive, early breast cancer: 10-Year follow-up results of
the French adjuvant study Group 05 randomized trial. J Clin Oncol.
23:2686–2693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brazda A, Estroff J, Euhus D, Leitch AM,
Huth J, Andrews V, Moldrem A and Rao R: Delays in time to treatment
and survival impact in breast cancer. Ann Surg Oncol. 17 (Suppl
3):S291–S296. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gagliato Dde M, Gonzalez-Angulo AM, Lei X,
Theriault RL, Giordano SH, Valero V, Hortobagyi GN and
Chavez-Macgregor M: Clinical impact of delaying initiation of
adjuvant chemotherapy in patients with breast cancer. J Clin Oncol.
32:735–744. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mortenson MM, Schneider PD, Khatri VP,
Stevenson TR, Whetzel TP, Sommerhaug EJ, Goodnight JE Jr and Bold
RJ: Immediate breast reconstruction after mastectomy increases
wound complications: However, initiation of adjuvant chemotherapy
is not delayed. Arch Surg. 139:988–991. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baek SH, Bae SJ, Yoon CI, Park SE, Cha CH,
Ahn SG, Kim YS, Roh TS and Jeong J: Immediate breast reconstruction
does not have a clinically significant impact on adjuvant treatment
delay and subsequent survival outcomes. J Breast Cancer.
22:109–119. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang JR, Kuo WL, Yu CC, Chen SC and Huang
JJ: Reconstructive outcome analysis of the impact of neoadjuvant
chemotherapy on immediate breast reconstruction: A retrospective
cross-sectional study. BMC Cancer. 21:5222021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Varghese J, Gohari SS, Rizki H, Faheem M,
Langridge B, Kümmel S, Johnson L and Schmid P: A systematic review
and meta-analysis on the effect of neoadjuvant chemotherapy on
complications following immediate breast reconstruction. Breast.
55:55–62. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
O'Connell RL, Rattay T, Dave RV, Trickey
A, Skillman J, Barnes NLP, Gardiner M, Harnett A, Potter S,
Holcombe C, et al: The impact of immediate breast reconstruction on
the time to delivery of adjuvant therapy: The iBRA-2 study. Br J
Cancer. 120:883–895. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goldhirsch A, Winer EP, Coates AS, Gelber
RD, Piccart-Gebhart M, Thürlimann B and Senn HJ; Panel members, :
Personalizing the treatment of women with early breast cancer:
Highlights of the St Gallen International expert consensus on the
primary therapy of early breast cancer 2013. Ann Oncol.
24:2206–2223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhong T, Hofer SO, McCready DR, Jacks LM,
Cook FE and Baxter N: A comparison of surgical complications
between immediate breast reconstruction and mastectomy: The impact
on delivery of chemotherapy-an analysis of 391 procedures. Ann Surg
Oncol. 19:560–566. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hamahata A, Kubo K, Takei H, Saitou T,
Hayashi Y, Matsumoto H, Nagai S, Inoue K, Kurosumi M, Yamaki T and
Sakurai H: Impact of immediate breast reconstruction on
postoperative adjuvant chemotherapy: A single center study. Breast
Cancer. 22:287–291. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
O'Halloran N, Lowery A, Curran C,
McLaughlin R, Malone C, Sweeney K, Keane M and Kerin M: A review of
the impact of neoadjuvant chemotherapy on breast surgery practice
and outcomes. Clin Breast Cancer. 19:377–382. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Riba J, de Romani SE and Masia J:
Neoadjuvant chemotherapy for breast cancer treatment and the
evidence-based interaction with immediate autologous and
implant-based breast reconstruction. Clin Plast Surg. 45:25–31.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Montemurro F, Nuzzolese I and Ponzone R:
Neoadjuvant or adjuvant chemotherapy in early breast cancer? Expert
Opin Pharmacother. 21:1071–1082. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
González-Santiago S, Saura C, Ciruelos E,
Alonso JL, de la Morena P, Santisteban Eslava M, Gallegos Sancho
MI, de Luna A, Dalmau E, Servitja S, et al: Real-world
effectiveness of dual HER2 blockade with pertuzumab and trastuzumab
for neoadjuvant treatment of HER2-positive early breast cancer (The
NEOPETRA Study). Breast Cancer Res Treat. 184:469–479. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hassett MJ, Li H, Burstein HJ and Punglia
RS: Neoadjuvant treatment strategies for HER2-positive breast
cancer: Cost-effectiveness and quality of life outcomes. Breast
Cancer Res Treat. 181:43–51. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Okamoto M, Tajiri W, Ueo H, Masuda T,
Ijichi H, Koga C, Nakamura Y, Taguchi K, Ohno S and Tokunaga E:
Efficacy of Adjuvant combination therapy with trastuzumab and
chemotherapy in HER2-positive early breast cancer: A single
institutional cohort study from clinical practice. Anticancer Res.
40:3315–3323. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sandberg LJ, Clemens MW, Symmans WF,
Valero V, Caudle AS, Smith B, Kuerer HM, Hsu L and Kronowitz SJ:
Molecular profiling using breast cancer subtype to plan for breast
reconstruction. Plast Reconstr Surg. 139:586e–596e. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee CN and Foster RD: Breast
reconstruction after mastectomy in young women. Breast Dis.
23:47–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang YC, Hu WY, Chang YM and Chiu SC:
Changes in sexual life experienced by women in Taiwan after
receiving treatment for breast cancer. Int J Qual Stud Health
Well-being. 14:16543432019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin PJ, Fang SY and Kuo YL: Development
and usability testing of a decision support app for women
considering breast reconstruction surgery. J Cancer Educ.
36:160–167. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Momoh AO, Griffith KA, Hawley ST, Morrow
M, Ward KC, Hamilton AS, Shumway D, Katz SJ and Jagsi R: Patterns
and correlates of knowledge, communication, and receipt of breast
reconstruction in a modern population-based cohort of patients with
breast cancer. Plast Reconstr Surg. 144:303–313. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
August DA, Wilkins E and Rea T: Breast
reconstruction in older women. Surgery. 115:663–668.
1994.PubMed/NCBI
|
